Jahns Boriana G, Stein Werner, Hilfiker-Kleiner Denise, Pieske Burkert, Emons Günter
Department of Gynecology and Obstetrics, Georg-August-University, Göttingen, Germany.
Am J Obstet Gynecol. 2008 Oct;199(4):e5-6. doi: 10.1016/j.ajog.2008.06.051.
Peripartum cardiomyopathy (PPCM) is a rare disease of unclear etiology with a frequent poor outcome, despite optimal medical therapy. Recent experimental data implicate a causal role of prolactin. We report a patient with PPCM who responded well to treatment with Bromocriptine in addition to standard therapy of heart failure.
围产期心肌病（PPCM）是一种病因不明的罕见疾病，尽管进行了最佳的药物治疗，但其预后往往较差。最近的实验数据表明催乳素起了因果作用。我们报告了一名围产期心肌病患者，除了心力衰竭的标准治疗外，该患者对溴隐亭治疗反应良好。
